Royal Sense Limited receives final approval from USFDA for products

Royal Sense Limited has received final approval on 15th April, 2025 from U.S. Food and Drug Administration (FDA) for the following category:

1. Nebulizer, medicinal, non-ventilatory (atomizer) - NEBULIZER; Nebulizer Kit; Nebulizer Mask.

2. Pump, nebulizer, electrically powered - Portable Nebulizer.

3. Pump, nebulizer, manual - Nebulizer.

Shares of Royal Sense Limited was last trading in BSE at Rs. 247.95 as compared to the previous close of Rs. 238.70. The total number of shares traded during the day was 13000 in over 11 trades.

The stock hit an intraday high of Rs. 250.10 and intraday low of 240.10. The net turnover during the day was Rs. 3208350.00.

Source : Equity Bulls

Keywords

INE0QQG01019 RoyalSense MedicalEquipmentSupplies USFDA FinalApproval Products